Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Sep;44(9):2108-2113.
doi: 10.1111/liv.16020. Epub 2024 Jun 27.

Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial

Enrico Pompili  1 , Maurizio Baldassarre  2 , Giulia Iannone  1 , Greta Tedesco  1 , Silvia Nardelli  3 , Salvatore Piano  4 , Carlo Alessandria  5 , Sergio Neri  6 , Francesco G Foschi  7 , Fabio Levantesi  8 , Paolo Caraceni  1   2 , Mauro Bernardi  1 , Giacomo Zaccherini  1   2 ; ANSWER Study Investigators
Collaborators, Affiliations
Randomized Controlled Trial

Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial

Enrico Pompili et al. Liver Int. 2024 Sep.

Abstract

Type-2 diabetes mellitus is a frequent comorbidity of cirrhosis independently associated with cirrhosis-related complications and mortality. This post hoc analysis of the ANSWER trial database assessed the effects of long-term human albumin (HA) administration on top of the standard medical treatment (SMT) on the clinical outcomes of a subgroup of 85 outpatients with liver cirrhosis, uncomplicated ascites and insulin-treated diabetes mellitus type 2 (ITDM). Compared to patients in the SMT arm, the SMT + HA group showed a better overall survival (86% vs. 57%, p = .016) and lower incidence rates of paracenteses, overt hepatic encephalopathy, bacterial infections, renal dysfunction and electrolyte disorders. Hospital admissions did not differ between the two arms, but the number of days spent in hospital was lower in the SMT + HA group. In conclusion, in a subgroup of ITDM outpatients with decompensated cirrhosis and ascites, long-term HA administration was associated with better survival and a lower incidence of cirrhosis-related complications.

Keywords: ascites; bacterial infections; diabetes mellitus; hepatic encephalopathy; long‐term albumin treatment; renal dysfunction; survival.

PubMed Disclaimer

References

REFERENCES

    1. Lee WG , Wells CI , McCall JL , Murphy R , Plank LD . Prevalence of diabetes in liver cirrhosis: a systematic review and meta‐analysis. Diabetes Metab Res Rev. 2019;35:e3157.
    1. Elkrief L , Rautou PE , Sarin S , Valla D , Paradis V , Moreau R . Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int. 2016;36:936‐948.
    1. Mantovani A , Csermely A , Petracca G , et al. Non‐alcoholic fatty liver disease and risk of fatal and non‐fatal cardiovascular events: an updated systematic review and meta‐analysis. Lancet Gastroenterol Hepatol. 2021;6:903‐913.
    1. Goh GB , Pan A , Chow WC , Yuan JM , Koh WP . Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese health study. Liver Int. 2017;37:251‐258.
    1. Sanyal AJ , Van Natta ML , Clark J , et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385:1559‐1569.

Publication types

LinkOut - more resources